 Possible Benefits for Treating SARS-CoV-2COVID-19 and mRNA Vaccine Side Effects KELOWNA, BC ACCESSWIRE July 21, 2021 Lexaria Bioscience Corp. NASDAQ:LEXXNASDAQ:LEXXW the Company or Lexaria, a global innovator in drug delivery platforms is pleased to announce that its tolerability and pharmacokinetic study VIRAL-A20-3 has been completed with positive results. This study demonstrated that DehydraTECHTM enabled colchicine, the latest of several drugs Lexaria has successfully tested with known SARS-CoV-2 antiviral properties, benefited from our proprietary formulation and processing, resulting in increased delivery: Drug Cmax Improvement ngmL Control ngmL AUClast Improvement hrngmL Control hrngmL Colchicine 31.97 91 p0.0005 16.73 104.43 167 p0.0028 38.97 Colchicine is an approved therapeutic with anti-inflammatory effects that is principally used to treat gout and conditions such as cardiac inflammation i.e. 